Physician profile
Tabitha M Satcher
NPI 1558043992
$1,588.61
in general payments reported to CMS, 2019-2025
19 companies · $794 in 2025
The $794 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22.68 · 2024: $772 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,588.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $363.96 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Cvrx, INC. | $323.43 | 2024-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $215.00 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $162.69 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.37 | 2024-2025 | Jardiance |
| Pfizer INC. | $80.16 | 2024-2025 | |
| Amgen INC. | $60.88 | 2024-2025 | Repatha, Repatha |
| Alnylam Pharmaceuticals INC. | $40.86 | 2025 | Onpattro |
| Convatec INC. | $38.88 | 2024 | |
| Esperion Therapeutics, INC. | $38.07 | 2025 | Nexletol |
| Merck Sharp & Dohme LLC | $37.72 | 2024-2025 | Verquvo |
| Recor Medical INC | $24.89 | 2025 | Paradise Ultrasound Renal Denervation System |
| Kiniksa Pharmaceuticals International, Plc | $21.60 | 2024 | Arcalyst |
| Daiichi Sankyo INC. | $18.70 | 2024 | Injectafer |
| Lexicon Pharmaceuticals, INC. | $16.04 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.30 | 2024 | Intellis Adaptivestim |
| Inari Medical, INC. | $14.84 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbvie INC. | $14.75 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $13.47 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Satcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.